Skip to content

Pulsed Electromagnetic Versus Hydrotherapy on Chronic Pelvic Pain

Enrolling by invitationNot applicableNCT07867808
View the official record on ClinicalTrials.gov

Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.

This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.

Brief summary (from the registry)

Pulsed electromagnetic field therapy and hydrotherapy are non-invasive treatment modalities that may alleviate chronic pelvic pain through pain modulation, reduction of inflammation, enhancement of circulation, and relaxation of pelvic musculature. Both interventions have demonstrated potential benefits in reducing pain severity and improving functional outcomes and quality of life in patients with chronic pelvic pain syndrome, supporting their investigation as therapeutic options in clinical research

Study details

Official title
Effect of Pulsed Electromagnetic Field Versus Hydrotherapy on Chronic Pelvic Pain Syndrome: A Randomized Controlled Trial
Interventions
  • Device: pulsed electromagnetic field
  • Device: hydrotherapy
  • Other: traditional physical therapy program
Sponsor
Horus University
Start date
2026-07-20
Primary completion
2026-10-30
Sex
Male
Age range
from 42 Years to 52 Years
Healthy volunteers
true
Results posted
No results posted in this snapshot
Countries
Jordan
Total sites listed
1

Eligibility criteria

Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * male patients aged 42 - 50 years * chronic non bacterial prostatitis * Diagnosis of Chronic Non-Bacterial Prostatitis/Chronic Pelvic Pain Syndrome (NIH Category III) confirmed by a urologist. * Presence of pelvic, perineal, suprapubic, testicular, penile, or ejaculatory pain for at least 3 months within the previous 6 months. * Stable medical treatment for at least 4 weeks before enrollment, if receiving medications. * Ability to understand study procedures and provide written informed consent. Willingness to refrain from initiating new treatments for prostatitis during the study period. Exclusion Criteria: * Diagnosis of acute bacterial prostatitis * History of prostate cancer, bladder cancer, or other pelvic malignancy * Previous prostate surgery within the last 12 months * Contraindications to hydrotherapy, including: Open wounds, Active skin infections, Uncontrolled epilepsy, Severe cardiac insufficiency

Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT07867808